ROVIPIA
Live / Registered — Registered (as of 01 Sept 2020)
What this means for you
Registered since 01 Sept 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79278237
- Registration number
- 6138770
- Mark type
- Stylized text
- Filed
- 02 Dec 2019
- Published for opposition
- 16 Jun 2020
- Registered
- 01 Sept 2020
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; biological preparations for the treatment of bacterial infections, viral infections, inflammatory disorders, fungal infections, cardiovascular diseases and disorders, dermatological conditions, respiratory diseases and disorders, central nervous system diseases and disorders, gastrointestinal diseases and disorders, kidney diseases, diabetes, hypertension, skin disorders, cancer and tumors, allergies, bone diseases, diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the Musculo-skeletal system and the genitourinary system; biological preparations for use in hematology and in tissue and organ transplantation; biological preparations for prevention and treatment of eye diseases and conditions; biological preparations for the prevention and treatment of heart rhythm disorders; biological preparations for the prevention and treatment of immune system related diseases and disorders and stem cells for pharmaceutical and medical use
- Class 044 — Medical, beauty and agricultural services: Collection and preservation of blood; collection and preservation services for tissue and cells, namely, collection and banking of umbilical cord tissue perivascular stem cells; medical diagnostic services; medical treatment services; provision of medical information and data for diagnosis and medical treatment
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 01 Sept 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 23 Jan 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 31 Dec 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 31 Dec 2020 — FINAL DISPOSITION PROCESSED
- 01 Dec 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 01 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
- 16 Jun 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jun 2020 — PUBLISHED FOR OPPOSITION
- 27 May 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 May 2020 — ASSIGNED TO LIE
- 29 Apr 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Apr 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Apr 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Apr 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Apr 2020 — REFUSAL PROCESSED BY IB